End-to-end contract development, research, and preparative manufacturing for small molecules, bioconjugates, peptides, and oligonucleotides. Anchored by a supercritical fluid platform that brings speed, selectivity, and green chemistry to every project.
Integrated contract development, research, and manufacturing services for pharmaceutical and biotech programs. From discovery through commercial supply, with a supercritical fluid platform threaded through every stage.
Route design, process development, and preparative manufacturing for active pharmaceutical ingredients, advanced intermediates, and new modalities. Phase-appropriate work from preclinical supply through commercial launch.
Discovery and medicinal chemistry, custom synthesis, hit-to-lead and lead optimization support, and reference-standard work. Embedded scientific teams for early-stage programs that need flexibility, not boilerplate.
Supercritical fluid chromatography and orthogonal liquid chromatography as a primary manufacturing tool — not a back-room enabling technology. Chiral resolution, impurity removal, and final-step polishing under appropriate quality systems.
Method development and validation across NMR, mass spectrometry, HPLC, GC, and orthogonal techniques. CMC support and regulatory dossier work tuned for cross-jurisdictional filings — from IND through marketing authorization.
We work across the modalities where modern drug discovery and development is moving — and where supercritical fluid chemistry genuinely earns its place alongside conventional approaches.
Active pharmaceutical ingredients and advanced intermediates across oncology, central nervous system, cardiovascular, anti-infective, and metabolic therapeutic areas. Route design, asymmetric synthesis, chiral resolution, and final-step polishing — with SFC available wherever it outperforms conventional approaches.
Antibody-drug conjugates, peptide-drug conjugates, and radionuclide-drug conjugates. Payload synthesis, linker chemistry, conjugation development, and drug-substance process work. SFC purification protects sensitive payloads where aqueous chromatography degrades them.
Solid-phase and solution-phase peptide synthesis, complex cyclic and stapled peptides, and peptide intermediates. Preparative chromatographic purification is the final-step workhorse for peptide therapeutics, and supercritical fluid methods extend the toolkit for difficult separations.
Phosphoramidite building blocks, modified nucleosides, and oligonucleotide intermediates for antisense, siRNA, and other oligo therapeutics. Anhydrous supercritical CO₂ environments protect moisture-sensitive intermediates during purification — a fit-for-purpose advantage over protic mobile phases.
Supercritical CO₂ is more than a mobile phase. We use it as a separation medium, an extraction solvent, a reaction medium, and a particle-engineering tool — bringing the same speed, selectivity, and green-chemistry benefits to every stage where conventional approaches fall short.
SFC for chiral resolution, achiral separation, and final-step polishing. Orthogonal selectivity to liquid chromatography resolves what HPLC cannot, and the low-viscosity mobile phase enables faster cycle times under gentler conditions.
SFE for natural-product isolation, residual-solvent removal, and selective extraction of thermally labile or sensitive compounds. Tunable density and selectivity, with no organic-solvent residues in the recovered product.
Supercritical CO₂ as a non-toxic, non-flammable, recoverable solvent for hydrogenation, oxidation, and other process-chemistry reactions. Reduced organic-solvent load and simplified downstream workup compared to conventional approaches.
Supercritical antisolvent and rapid-expansion processing for controlled particle size, morphology, and polymorph selection. Useful for poorly soluble APIs, inhalation formulations, and amorphous solid dispersions where conventional milling falls short.
A clear path from project scoping through material delivery, with the same partners and the same quality system at every step.
Scope the program, assess feasibility, and align on target profile, timeline, and quality expectations
Route design, process and method development, screening and optimization across synthetic and analytical work
Preparative chromatographic and synthetic manufacturing under phase-appropriate quality oversight
Material with full analytical and quality documentation, plus transferable methods for downstream work
Discovery, development, manufacturing, and analytical sciences under one roof — purpose-built to move programs from concept through delivery without handoff friction.
Medicinal chemistry, custom synthesis, building-block libraries, and route scouting. Embedded teams that work alongside discovery scientists rather than waiting at the end of a queue.
SFC, SFE, supercritical reaction medium work, and particle engineering under one platform. The technology stack runs through every modality we serve — from small molecules to peptides to oligonucleotides.
NMR, mass spectrometry, HPLC, GC, and orthogonal analytical techniques tied to a quality system that grows with the program — from early discovery through later-phase development.
A small-molecule API that needs a new route. A bioconjugate program that needs payload-linker work. A peptide or oligonucleotide intermediate that needs purification. Tell us about the project — we will scope it together.
A description of the program, the target profile, the modality, the stage of development, and the constraints that matter to you. We will assess fit, suggest a path, and propose an engagement within a few business days.
Scoping and feasibility, then a structured development phase, then preparative work and material delivery — with a single point of contact and a single quality system throughout. Confidentiality agreements available at first contact.
Our team responds within one business day. CDAs available upon request.